BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26645993)

  • 1. Further observations on the clinical significance and inheritance of the low-frequency platelet antigen HPA-28bw.
    Lucas G; Poles A; Woźniak MJ; Gilmore R
    Transfusion; 2016 Apr; 56(4):873-7. PubMed ID: 26645993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia.
    Poles A; Woźniak MJ; Walser P; Ridgwell K; Fitzgerald J; Green A; Gilmore R; Lucas G
    Transfusion; 2013 Sep; 53(9):1965-73. PubMed ID: 23305224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases.
    Ghevaert C; Rankin A; Huiskes E; Porcelijn L; Javela K; Kekomaki R; Bakchoul T; Santoso S; Nutland S; Smyth DJ; Smith GA; McBride S; Watkins NA; Ouwehand WH
    Transfusion; 2009 Oct; 49(10):2084-9. PubMed ID: 19500319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
    Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
    Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.
    Peterson JA; Gitter ML; Kanack A; Curtis B; McFarland J; Bougie D; Aster R
    Transfusion; 2010 Feb; 50(2):324-33. PubMed ID: 19821948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
    Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
    BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
    Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
    Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.
    Kroll H; Yates J; Santoso S
    Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia.
    Kroll H; Feldmann K; Zwingel C; Hoch J; Bald R; Bein G; Bayat B; Santoso S
    Transfusion; 2011 Aug; 51(8):1745-54. PubMed ID: 21332723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies.
    Hopkins M; Lucas G; Calvert A; Bendukidze N; Green F; Kotecha K; Poles A
    Transfusion; 2017 May; 57(5):1267-1271. PubMed ID: 28236317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal alloimmune thrombocytopenia caused by an antibody specific for a newly identified allele of human platelet antigen-7.
    Koh Y; Taniue A; Ishii H; Matsuyama N; Amakishi E; Hayashi T; Furuta RA; Fukumori Y; Hirayama F; Yoshimura K; Nagamine T; Tamai S; Nakano S
    Transfusion; 2010 Jun; 50(6):1276-84. PubMed ID: 20070614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe HPA-15b related neonatal alloimmune thrombocytopenia.
    Moncharmont P; Courvoisier S; Pagnier A; Cotta L; Debillon T; Rigal D
    Acta Paediatr; 2007 Nov; 96(11):1701-3. PubMed ID: 17850392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of alloimmune neonatal thrombocytopenia.
    Blanchette VS; Johnson J; Rand M
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
    Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C
    Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetomaternal alloimmune thrombocytopenia.
    Ahya R; Turner ML; Urbaniak SJ;
    Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Campbell K; Stafford P; Metcalfe P; Casbard A; Smith GA; Allen D; Ranasinghe E; Williamson LM; Ouwehand WH
    Transfusion; 2007 Jul; 47(7):1296-305. PubMed ID: 17581167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.